Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Oral minoxidil may effectively treat hair loss from chemotherapy.

There is an urgent need for better treatments for hair loss caused by chemotherapy.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Erythropoietin helps hair grow and could be a potential treatment for hair loss.

Testosterone injections can cause skin darkening and thickening.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Iron and zinc levels in hair are not linked to hair loss from chemotherapy.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Hair is thinner near the scalp in acute hair shedding conditions.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

The document concludes that while some hair and scalp disorders can be treated, hair loss from destroyed follicles is permanent, and damaged hair can only regrow naturally.

New gene mutations linked to skin conditions were found, bacteria and chemicals may worsen acne, a dog mutation could exist in humans, virus-like elements might be involved in psoriasis, and a vitamin D3 treatment doesn't prevent chemotherapy-related hair loss.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

No treatment fully prevents hair loss from chemotherapy yet.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Facial dark spots can be caused by the sun, genetics, makeup, or medicine, and are diagnosed by patient history and skin tests.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Vitamin E in the diet might help protect against hair loss caused by the chemotherapy drug doxorubicin in rabbits.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

The document concludes that skin and nail changes can indicate various underlying health conditions.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.